T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
XYZ
Block Inc
XYZ
|
+$2.39B |
| 2 |
Carvana
CVNA
|
+$1.82B |
| 3 |
Microsoft
MSFT
|
+$1.5B |
| 4 |
Walt Disney
DIS
|
+$1.25B |
| 5 |
Spotify
SPOT
|
+$1.05B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$2.65B |
| 2 |
Intuit
INTU
|
+$2.08B |
| 3 |
Match Group
MTCH
|
+$1.87B |
| 4 |
Salesforce
CRM
|
+$1.76B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.61B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.08% |
| 2 | Healthcare | 16.24% |
| 3 | Consumer Discretionary | 15.33% |
| 4 | Communication Services | 13.82% |
| 5 | Financials | 12.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
626
Seacoast Banking Corp of Florida
SBCF
$3.47B
| $158M | 0.01% |
4,685,828
-50,350
| -1% | -$1.59M |
|
627
Pool Corp
POOL
$7.2B
| $158M | 0.01% |
363,264
-93,323
| -20% | -$44.2M |
|
628
Douglas Emmett
DEI
$1.97B
| $158M | 0.01% |
4,983,849
+465,146
| +10% | +$15.3M |
|
629
Acadia Pharmaceuticals
ACAD
$5.06B
| $157M | 0.01% |
9,432,544
-766,287
| -8% | -$14.8M |
|
630
Harmonic Inc
HLIT
$1.55B
| $155M | 0.01% |
17,745,038
+5,138
| +0% | +$46K |
|
|
IGMS
631
DELISTED
IGM Biosciences
IGMS
| $155M | 0.01% |
2,357,464
+371,393
| +19% | +$28.4M |
|
632
Consolidated Edison
ED
$40B
| $154M | 0.01% |
2,124,340
-40,242
| -2% | -$3M |
|
633
Liberty Energy
LBRT
$3.53B
| $153M | 0.01% |
12,628,540
-1,238,346
| -9% | -$13.7M |
|
|
OZON
634
DELISTED
Ozon Holdings PLC American Depositary Shares, each ADS representing one ordinary share
OZON
| $153M | 0.01% |
3,031,997
-40,249
| -1% | -$2.11M |
|
|
AIV
635
Aimco
AIV
$379M
| $153M | 0.01% |
22,290,072
+25,543
| +0.1% | +$176K |
|
|
TGI
636
DELISTED
Triumph Group
TGI
| $150M | 0.01% |
8,046,120
+56,632
| +0.7% | +$1.06M |
|
|
MODV
637
DELISTED
ModivCare
MODV
| $150M | 0.01% |
823,990
-8,885
| -1% | -$1.58M |
|
638
Payoneer
PAYO
$2.42B
| $149M | 0.01% |
17,414,694
+13,664,336
| +364% | +$133M |
|
639
Matador Resources
MTDR
$6.43B
| $148M | 0.01% |
3,903,058
-529,276
| -12% | -$16.2M |
|
640
Hanover Insurance
THG
$7.81B
| $148M | 0.01% |
1,144,365
-12,861
| -1% | -$1.75M |
|
641
AerCap
AER
$23.6B
| $148M | 0.01% |
2,559,602
+2,467,157
| +2,669% | +$132M |
|
|
CNH
642
CNH Industrial
CNH
$16.9B
| $147M | 0.01% |
9,946,567
-4,290,576
| -30% | -$61.6M |
|
643
C.H. Robinson
CHRW
$17.3B
| $147M | 0.01% |
1,691,586
-788,823
| -32% | -$71.4M |
|
|
SIVB
644
DELISTED
SVB Financial Group
SIVB
| $147M | 0.01% |
226,819
+4,363
| +2% | +$2.53M |
|
|
AESC
645
DELISTED
The AES Corporation
AESC
| $146M | 0.01% |
1,526,687
+10,588
| +0.7% | +$1.07M |
|
646
Pacific Biosciences
PACB
$342M
| $145M | 0.01% |
5,749,336
+2,214,524
| +63% | +$65.6M |
|
647
McCormick & Company Non-Voting
MKC
$14.4B
| $145M | 0.01% |
1,792,200
+43,062
| +2% | +$3.7M |
|
648
Weibo
WB
$1.89B
| $145M | 0.01% |
3,053,757
+292,265
| +11% | +$15.8M |
|
649
Ulta Beauty
ULTA
$22.4B
| $145M | 0.01% |
400,950
+35,369
| +10% | +$12.8M |
|
650
US Bancorp
USB
$102B
| $144M | 0.01% |
2,427,476
-38,868
| -2% | -$2.21M |
|
Similar funds
T. Rowe Price Associates's Q3 2021 Portfolio in Review
As of Q3 2021, T. Rowe Price Associates held 3,048 positions worth $1.06T, down 1.6% from $1.08T the previous quarter. Its ten largest holdings account for 26% of the portfolio.
T. Rowe Price Associates's Q3 2021 filing shows 131 new, 1,029 increased, 1,524 reduced and 112 closed positions. Its largest new stake was Warby Parker: 17,643,113 shares worth $936M. The largest sale was Visa, an estimated $2.65B.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q3 2021 buy was Warby Parker: 17,643,113 shares worth $936M.
- T. Rowe Price Associates added most to Block Inc in Q3 2021, an estimated $2.39B increase.
- T. Rowe Price Associates's biggest Q3 2021 reduction was Visa, cutting an estimated $2.65B.
- T. Rowe Price Associates fully exited Maxim Integrated Products in Q3 2021, selling an estimated $394M.
- T. Rowe Price Associates's ten largest holdings make up 26% of its $1.06T portfolio in Q3 2021.
- T. Rowe Price Associates opened 131 new positions and closed 112 in Q3 2021.
- T. Rowe Price Associates's portfolio value fell 1.6% quarter-over-quarter to $1.06T.
Based on T. Rowe Price Associates's 13F filing for Q3 2021, filed 15 Nov 2021.